DSP Merrill Lynch Ltd has submitted to BSE a copy of the Press Release made by Novartis AG as regards the open offer to acquire up to approximately 39% of its Indian subsidiary Novartis India Ltd at a price of Rs 351 per share.
Dear VKK$,
Do you think price for buy back announced is correct or they have to revise the same after one more week of announcement.
Your views are most imp for me as I was very much tempted to book long term profit in this stock at 317.
I am still completely invested in this counter a son date
Dear VKK4,
thanks for your kind advise and i also have a feeling Novarites will not get much stocks if buy back price is kept at 351.
It has to be more a than 500 by all means.
Today it crossed 351 and volumes were not that high.
I cannot say. Yesterday I posted one msg to robin_gupta and it was posted in the inbox of tara 23.
One msg from a boarder posted on Akruti thread was posted to me in Sterlite thread. Surprised.